Hayashi, Y. et al. 2025. Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis. Journal of Hematology. (Jan. 2025). DOI:https://doi.org/10.14740/jh2010.